Gene Editing Therapy Start-up Secures $3.4 Million Grant for Duchenne Research
MyoGene Bio has received a $3.4 million grant from the California Institute of Regenerative Medicine to advance its pre-clinical gene-editing studies in Duchenne, thanks to support from Parent Project Muscular Dystrophy (PPMD), Duchenne UK, and…Learn More
